Back to Search
MATTHEW KAUFMANN, MD, MBA
MD, MBA
Anesthesiology Physician
NPI: 1245740299IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
323166(NY)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
BOSTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2019
Research & Publications (20)
Origins of the sample-size effect in explicit evaluative judgment.
PMID 19447750·Exp Psychol·2009
8-other
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.
PMID 17998286·Ann Oncol·2007
6-review
Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.
PMID 17563395·J Clin Oncol·2007
4-observational
A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93.
PMID 17897821·Eur J Cancer·2007
4-observational
Extended breast cancer treatment with an aromatase inhibitor (Letrozole) after tamoxifen: why, who and how long?
PMID 16621229·Eur J Obstet Gynecol Reprod Biol·2006
6-review
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.
PMID 16622270·J Clin Oncol·2006
6-review
Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
PMID 16258087·J Clin Oncol·2005
4-observational
Long-term risk of breast cancer recurrence: the need for extended adjuvant therapy.
PMID 15915367·J Cancer Res Clin Oncol·2005
6-review
Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer.
PMID 12888366·Eur J Cancer·2003
3-trial
International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations.
PMID 12829681·J Clin Oncol·2003
6-review
Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: results of a phase III randomized double-blind trial. The Exemestane Study Group.
PMID 10735887·J Clin Oncol·2000
3-trial
Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen. results Of a double-blind randomised phase III trial.
PMID 11056333·Eur J Cancer·2000
3-trial
Do we need better prognostic factors in nodal-negative breast cancer? Contra.
PMID 10708929·Eur J Cancer·2000
8-other
Exemestane improves survival in metastatic breast cancer: results of a phase III randomized study.
PMID 11970744·Clin Breast Cancer·2000
3-trial
Data-driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer.
PMID 19455418·Breast Cancer Res Treat·2010
1-meta
Rapid identification of uropathogenic Escherichia coli of the O25:H4-ST131 clonal lineage using the DiversiLab repetitive sequence-based PCR system.
PMID 19416293·Clin Microbiol Infect·2010
8-other
Multiple mechanisms induce ectopic expression of LYL1 in subsets of T-ALL cell lines.
PMID 19608273·Leuk Res·2010
8-other
Correspondence (letter to the editor): imaging is not sufficient.
PMID 19568382·Dtsch Arztebl Int·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 400 E MAIN ST
MOUNT KISCO, NY 10549 - Phone
- (914) 666-1200
Quick Facts
- NPI
- 1245740299
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile